Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics
Frontiers in Cellular and Infection Microbiology · 01.07.2025 · 15
DOI: 10.3389/fcimb.2025.1595884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 01.07.2025. Verfasst von Macarena Orejudo und 40 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro…. Hauptthemen laut MEDLINE: Feces, Metagenomics, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Introduction
Dysbiosis is a key mechanism in inflammatory bowel disease (IBD) pathophysiology. Previous microbiota studies in IBD generally have involved patients treated with immunosuppressive agents, which can affect the results. We aimed to elucidate the fecal microbiota composition in newly diagnosed treatment-naïve IBD patients.
Methods
Microbiota from stool samples were investigated using shotgun metagenomics sequencing and subsequent bioinformatics analysis.
Results
A total of 103 patients with Crohn's disease (CD), 144 with ulcerative colitis (UC), and 49 healthy controls (HC) were included. CD patients had significantly lower species-level diversity than those with UC and HC. CD subgroups with Ileocolonic location and stricturing behavior showed reduced diversity compared to HC. A negative correlation was observed between endoscopic severity and microbial diversity in CD patients. UC patients had similar microbial diversity to HC, which was unaffected by disease activity. Taxonomic abundance analysis revealed a tendency towards a higher relative abundance of Escherichia coli and a lower relative abundance of Faecalibacterium prausnitzii in IBD patients compared to HC. However, the most significant differences in these patients compared to HC were observed in less abundant species, such as Toxoplasma gondii, Gemella morbillorum, and several species of the Adlercreutzia genera. Functional analysis in these patients highlighted changes in carbohydrate and nucleotide pathways.
Discussion
Our data suggest that newly diagnosed CD patients show significant microbiota composition disparities compared to UC patients and HC. Microbiota differences in these patients are linked to dysbiosis, characterized by a reduction in beneficial genera such as Gemella and Adlercreutzia, and a rise in pathogenic species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digesti…
- Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
- Gastroenterology Department, Hospital Universitario Central de Asturias and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain.
- Gastroenterology Department, Hospital Universitario Marqués de Valdecilla, Grupo de Investigación Clínica y Traslacional en Enfermedades Digestivas, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
- Hospital General Universitario Dr Balmis de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD),…
- Gastroenterology Department, Hospital Universitario de Galdakao, Galdakao, Vizcaya, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Orejudo, M., Gómez, M. J., Riestra, S., Rivero, M., Gutiérrez, A., Rodríguez-Lago, I., Fernández-Salazar, L., Ceballos, D., Benítez, J. M., Aguas, M., Bastón-Rey, I., Bermejo, F., Casanova, M. J., Lorente-Poyatos, R. H., Ber, Y., Ginard, D., Esteve, M., de Francisco, R., García, M. J., …, & Chaparro, M. (2025). Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1595884
Vancouver
Orejudo M, Gómez MJ, Riestra S, Rivero M, Gutiérrez A, Rodríguez-Lago I, et al. Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1595884
BibTeX
@article{Orejudo2025,
author = {Orejudo, Macarena and Gómez, Manuel J and Riestra, Sabino and Rivero, Montserrat and Gutiérrez, Ana and Rodríguez-Lago, Iago and Fernández-Salazar, Luis and Ceballos, Daniel and Benítez, José Manuel and Aguas, Mariam and Bastón-Rey, Iria and Bermejo, Fernando and Casanova, María José and Lorente-Poyatos, Rufo H and Ber, Yolanda and Ginard, Daniel and Esteve, María and de Francisco, Ruth and García, María José and Francés, Rubén and Rodríguez, Ainhoa and Alcaide Suárez, Noelia and Guerra Del Río, Elena and Soto, Pilar and Nos, Pilar and Barreiro-de Acosta, Manuel and Guerra, Iván and Hervías Cruz, Daniel and Domínguez Cajal, Manuel and Royo, Vanesa and Aceituno, Montserrat and Aldars-García, Laila and Garre, Ana and Ramírez, Cristina and Soleto, Irene and Schuppe-Koistinen, Ina and Engstrand, Lars and Baldán-Martín, Montse and Sánchez-Cabo, Fátima and Gisbert, Javier P and Chaparro, María},
title = {Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1595884}
}
EUVIMED